InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.15
(
0.46%
)
Bitcoin
63,743.07
(
-0.23%
)
Post# of 3652
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Mcgill

Send PM Follow Ignore
Followers 2
Posts 330
Boards Moderated 0
Alias Born 10/23/2015

Mcgill

Re: None

Tuesday, 08/02/2016 11:26:34 AM

Tuesday, August 02, 2016 11:26:34 AM

Post# of 3652
GOVX is awarded $7.8 million contract.
The base portion of the contract, with a value of $199,442, will support preparatory work for initiation of manufacturing. The contract also includes $7.6 million in additional development options that may be exercised by NIAID, bringing the total potential value of the contract to $7.8 million. The multi-year contract will pay 100% of the manufacturing cost of the DNA vaccine component of GeoVax's HIV vaccine candidate, GOVX-B11.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up